- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05934591
Improving Attendance in Community Wise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rates of alcohol and substance misuse (ASM) in low-income, predominantly African American communities (from here on marginalized communities) are similar to the general population. However, ASM has greater consequences (e.g., higher incarceration and HIV/HCV infection rates) for residents in these communities. While the etiology underpinning this inequity is complex, the root cause of these issues has been traced to social determinants of health (SDH; e.g., stigma; poverty; barriers to education, housing, and employment).
Funded by the National Institute for Minority Health Disparities (NIMHD 5R01MD010629), in partnership with the Critical Consciousness Collaborative Board (3CB), we developed Community Wise (CW), a multi-level manualized behavioral intervention to decrease ASM frequency in a population of self-identified men with histories of substance use disorder (SUD) and incarceration in Essex County, NJ, U.S. The 3CB was founded in 2010 and developed and pilot-tested the original CW. Over the past six years, our team used the multiphase optimization strategy (MOST), and community based participatory research (CBPR) principles to develop and optimize CW for efficacy in reducing ASM and cost. MOST is an innovative methodological framework that employs experimental designs to engineer efficient and effective behavioral interventions. MOST guided the optimization of CW with delivery cost of less than $2,000 per intervention cycle serving up to ten individuals simultaneously (this was the Medicaid allowable reimbursement cost for SUD group treatment services in 2015). Clinical trial results showed larger ASM reduction (Cohen's d=-2∙22, P=0∙067) in the optimized CW group. Unfortunately, attendance across the 15 intervention sessions was low (only 15% of participants attended 50% of the sessions). Low attendance was due to the intervention's closed group format, the study's randomization strategy, and instability of the study's population (homelessness, poverty).
In order to improve upon our positive results and maximize our chances to successfully obtain further external funding to test CW effectiveness, we need funding to: 1) identify strategies to improve attendance and reduce ASM, and 2) to test feasibility and acceptability of CW among men and women with a history of SUD living in marginalized communities. We will achieve these aims by conducting a 23 full factorial experiment. This study will help us identify efficient strategies for improving attendance and, hence, maximize the interventions' effect in reducing ASM. As a highly efficient experimental design, a full factorial experiment will maximize study power and allow us to examine the individual and interactive contributions of each intervention delivery strategy on intervention attendance. MOST will inform which strategies will be retained, thus minimizing waste of resources. The current proposed research will also be conducted in partnership with the 3CB. As our primary individual level outcome, we will use number of sessions attended to test if different intervention delivery strategies will result in a clinically and statistically important intervention attendance with a minimum of 50% of participants attending at least 50% of the intervention. We will also compare the effect of different strategies on reducing ASM. Intervention delivery strategies include: 1) Recruiting individuals under supervision (those on parole, drug court, probation, or methadone maintenance); 2) Incentivizing intervention attendance; and 3) Delivering the intervention in an open group format. We will also compare intervention satisfaction measures between intervention strategies.
We will expand eligibility criteria to include women and people with SUD living in marginalized communities who have not been previously incarcerated. While women comprise a smaller percentage of people with SUD, they experience significant barriers to SUD treatment. Our pilot study showed that women started the CW intervention with worse outcomes when compared to men but had significantly higher reductions of ASM. While the original CW intervention was developed with and for formerly incarcerated people, it addresses concepts that are relevant to all people with SUD living in marginalized communities. Hence, the 3CB has recommended that we expand our eligibility criteria to reach a more diverse group of people. Our 23 full factorial design will examine change in attendance (N=144). Data will be collected at baseline and three months post-baseline. This study will impact public health as it will improve the potency of an optimized multi-level intervention adaptable to address different health inequities.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Liliane Windsor, PhD
- Phone Number: 217-300-1782
- Email: lwindsor@illinois.edu
Study Locations
-
-
Illinois
-
East Saint Louis, Illinois, United States, 62201
- Recruiting
- Comprehensive Behavioral Health Center
-
Contact:
- Liliane Windsor, PhD
- Phone Number: 217-300-1782
- Email: lwindsor@illinois.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Living in St. Clair County, Illinois (IL)
- Over 18
- English- speaker
- Under supervision (parole, probation, drug court or methadone maintenance)
- Having an alcohol or substance misuse disorder
Exclusion Criteria:
- Not living in St. Clair County, IL
- Not able to speak English
- Not able or willing to provide consent
- Not having an alcohol or substance misuse disorder
- Under 18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Population Type: Under Supervision or Not Under Supervision
1 group of 24 people under supervision (those on parole, drug court, probation, or methadone maintenance) and 1 group of 24 people not under supervision (those on parole, drug court, probation, or methadone maintenance) will attend groups of the Community Wise intervention.
|
The intervention received by each group will be Community Wise, a multi-level manualized behavioral intervention to decrease alcohol and substance misuse frequency
|
Experimental: Participation Incentive: Paid and Not Paid
1 group of 24 people will receive a financial incentive and 1 group of 24 people will not receive a financial incentive for attending the Community Wise intervention.
|
The intervention received by each group will be Community Wise, a multi-level manualized behavioral intervention to decrease alcohol and substance misuse frequency
|
Experimental: Group Type: Open and Closed Group Format
1 group of 24 people will attend a closed group format and 1 group of 24 people will attend an open group format of the Community Wise intervention.
|
The intervention received by each group will be Community Wise, a multi-level manualized behavioral intervention to decrease alcohol and substance misuse frequency
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of sessions attended
Time Frame: nine weeks
|
We will test if different intervention delivery strategies will result in a clinically and statistically important intervention attendance with a minimum of 50% of participants attending at least 50% of the intervention
|
nine weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UIUC IRB 23828
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intervention Engagement and Retention
-
Education University of Hong KongRecruitingAutism Spectrum Disorder | Social Engagement | Robotic InterventionHong Kong
-
Intermountain Health Care, Inc.University of UtahActive, not recruiting
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDropout | Attendance and Truancy | Student EngagementUnited States
-
Autism SpeaksUniversity of California, Los Angeles; Vanderbilt University; Hugo W. Moser Research...CompletedJoint Engagement + Enhanced Milieu Training | Joint Engagement + Enhanced Milieu Training+Augmentative Communication (AAC)United States
-
Mbarara University of Science and TechnologyUniversity of Calgary; Alberta Children's Hospital Research Institute; The ELMA... and other collaboratorsNot yet recruitingVentilation Skills Acquisition and Retention | Ventilation Knowledge Acquisition and Retention
-
University of RwandaCompletedPatient EngagementRwanda
-
University of California, San FranciscoCompletedInpatient Pediatric Engagement and Shared Decision-Making
-
University of HaifaCompletedPsychological Intervention | Internet-Based Intervention | Intervention StudyIsrael
-
Sanjiv Narayan, MD, PhDWithdrawnAnxiety | Patient Engagement | ICDUnited States
-
Rijnstate HospitalCompletedHypotension | Diuresis | Bladder Retention VolumeNetherlands
Clinical Trials on Community Wise
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Health services; Alberta...Completed
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNot yet recruiting
-
EBR Systems, Inc.Active, not recruitingHeart FailureUnited States, Australia, United Kingdom, Germany, Italy, France, Netherlands
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Completed
-
Mathematica Policy Research, Inc.UnknownSexual Behavior | Sexually Transmitted Infections
-
University of Wisconsin, MadisonRecruitingCommunication ResearchUnited States
-
Duke UniversitySuspended
-
National Yang Ming UniversityWithdrawn
-
Vastra Gotaland RegionRegion Östergötland; Region Skane; Dalarna County Council, Sweden; Region Örebro... and other collaboratorsNot yet recruitingSurgery | Melanoma (Skin)
-
Wise S.r.l.Fondazione Don Carlo Gnocchi Onlus; GenaeCompletedEpilepsy | Brain Tumor AdultSwitzerland, Germany, Italy